Healthcare Logic for Growth

For small and emerging healthcare companies, cash flow can be the difference between commercial success and closing the doors. Long healthcare sales cycles, expensive clinical and regulatory requirements, and delayed customer payments can quickly drain limited financial resources—even when a company has a promising product and strong market demand. In this episode of Healthcare Logic for Growth, w...

In the final episode of our 10-part Texas Rural Health Transformation Program series, Healthcare Logic for Growth brings everything together with a practical Go Forward Strategy for rural hospitals, Rural Health Clinics, and healthcare partners. We explore the most important lessons from the series, the opportunities and risks facing rural healthcare organizations, and six practical steps for turn...

In Episode 9 of Healthcare Logic for Growth, Eric Marr examines the Rural Health Transformation Program from the vendor's perspective. As Texas implements its Rural Texas Strong strategy, technology companies, telehealth providers, workforce organizations, consultants, cybersecurity firms, analytics companies, remote patient monitoring providers, and other healthcare vendors may have opportunities...

In this episode of Healthcare Logic for Growth, Eric Marr examines how rural hospitals and Rural Health Clinics can move from identifying an RHTP funding opportunity to designing a project that is practical, measurable, and sustainable. The episode introduces a simple approach to project design built around five questions: What problem are we solving? Who is affected? What will we do differently?...

Texas put its first Rural Texas Strong dollars into Make Rural Texans Healthy Again - and buried in the fine print is a pay-for-performance structure that reserves most outcome-based payments for Years 4 and 5. In this episode, Eric Marr unpacks what that means for rural hospital districts, hospitals, clinics, FQHCs, and behavioral health providers; why behavioral health is threaded through the pr...

What Technology, telehealth, AI, and cybersecurity are one of Texas's core, funded Rural Texas Strong focus areas — not a side track. Why It Matters Texas holds the largest first-year RHTP award in the country ($281.3M FY2026, ~$1.4B over five years), and this focus area sits inside three of its six initiatives. The Catch AI/telehealth and patient-tech dollars flow through cooperatives (CINs, ACOs...

Texas landed the largest single state award in the $50 billion Rural Health Transformation Program - $281.3 million in year one, on the way to $1.4 billion over five years. A major piece of that money, Rural Texas Strong's Initiative Four, is earmarked for rural workforce recruitment and retention. In this episode, Eric Marr breaks down what the workforce funding actually requires - the five-year...

A look at what's actually happening in the rural care market this month — why September 2026 is a hinge point for RHTP funding, what the rise of private equity ownership means for rural hospital boards, and three real turnaround stories (Grande Ronde Hospital, an RSM-led revenue cycle turnaround, and Bingham Memorial Hospital) that show a path forward without waiting on new federal money. In this...

Rural Texas Strong: The Six Required Initiative Areas The six initiative areas recapped: Make Rural Texans Healthy Again – Prevention and chronic disease grants to rural hospital districts. Rural Texas Patients in the Driver's Seat – Patient portals and health information exchange, procured through networks. Lone Star Advanced AI and Telehealth – Telehealth, remote monitoring, and predictive tools...

Texas’ Rural Health Transformation Program creates a meaningful opportunity to strengthen access, prevention, workforce capacity, technology, telehealth, cybersecurity, and rural clinical infrastructure. In this episode, we explore why FQHCs and RHCs should be viewed as the rural care front door. These organizations often provide the first point of contact for patients, support chronic-disease man...

Episode Takeaways RHTP is meaningful transformation funding, but it does not fully offset the financial losses, reimbursement pressures, debt, and closure risks facing many rural hospitals. Texas is expected to receive about 281 million dollars annually from RHTP, but its large rural population means the first-year allocation is approximately 66 dollars per rural resident. Rural hospitals should c...

In this episode we cover: Texas has more at-risk rural hospitals than any other state in the country — and the $50 billion Rural Health Transformation Program just arrived to try to change that. We break down what Rural Texas Strong actually funds, and why the math doesn't yet match the scale of the crisis.   Key Topics: 01 Texas has the most at-risk rural hospitals (50) of any U.S. state 02 What...

Too many healthcare companies build the product before mapping the reimbursement pathway. And that mismatch - between clinical value and commercial reality - is what stalls otherwise good businesses. The market is only getting less forgiving of that gap. The fix requires discipline: map the pathway, identify the real buyer, build evidence for that buyer specifically, and sequence your commercializ...

In Q1 2026, nearly 60% of digital health investment went to just 12 mega-deals of $100 million or more. This episode breaks down what this funding concentration means for startups and smaller healthcare companies, and provides a practical go-forward strategy for navigating the new reality. Key Topics Covered: The mega-deal phenomenon and what's driving it Why mid-tier and early-stage companies are...

In this episode of Healthcare Logic for Growth, we talked about why digital health companies must prove clinical value, not just engagement. We covered why activity metrics like downloads and retention are no longer enough on their own, why investors and health systems want stronger evidence, and why startups often struggle to generate proof within limited runway. We also walked through a practica...

Why growing in home health care requires a new staffing, reimbursement, and service design model—and what small agencies need to check before accepting new referrals. Key Topics: The myth that home health care is just cheaper facility care Drive-time-adjusted staffing ratios Setting-specific reimbursement realities Service design for the home environment Evaluating referrals by payer mix and margi...

In this episode of Healthcare Logic for Growth, we break down the pivotal trends from the first half of 2026 that every small and start-up healthcare company needs to know. We explore the good news (rebounding venture funding, FDA fast-track vouchers, and digital health pilot programs), the bad news (FDA staffing shortages, drug pricing uncertainty, and OMB grant threats), and the "data trap" catc...

In this episode of Healthcare Logic for Growth, we break down what healthcare startups need to do to succeed - and why so many fail. We cover the five biggest success factors, including solving a real problem, proving outcomes, building the payment model early, fitting into clinical workflows, and scaling with trust. We also look at five common failure patterns, including weak validation, no reimb...

The MFN drug pricing framework - what began as voluntary agreements with sixteen of the largest pharmaceutical companies - is now moving toward mandatory rules that will reach smaller biotechs and pharma companies. At the same time, a 100% pharmaceutical tariff takes effect September 29th for smaller manufacturers, with a lower 20% rate available only to companies that have engaged the MFN framewo...

Healthcare is full of great products that never became great businesses. In this first episode of the Healthcare Startup Revenue Series, we break down 4 of the structural barriers that accelerate performance: Buyer vs. user separation Long purchasing cycles The evidence requirement Economic model misalignment Whether you’re still in your first year of commercial activity or stuck at early customer...

On May 1, 2026, the CMS BALANCE Model went live - opening the door for Medicaid agencies to begin enrolling in a new federal framework that expands GLP-1 coverage for obesity and metabolic disease. The Medicare GLP-1 Bridge follows on July 1st, giving Medicare Part D beneficiaries access to these drugs at $50 per month. Most of the conversation has focused on Novo Nordisk and Eli Lilly. This episo...

Healthcare is deploying AI tools at more than twice the rate of the broader economy — and for the first time at meaningful scale, the ROI is real and documented. In this episode, we unpack the NVIDIA State of AI in Healthcare 2026 survey and this week's Healthcare IT News report on AI payment alignment to answer the question every small healthcare company is quietly asking: what does the AI inflec...

On May 1st, 2026, Nebraska became the first state in the country to enforce Medicaid work requirements under the One Big Beautiful Bill Act - the sweeping federal law that includes nearly a trillion dollars in Medicaid cuts over ten years. Montana goes live July 1st. Iowa in December. And 43 states are federally required to follow by January 1st, 2027. In this episode, we break down what this mean...

On April 23, 2026, the FDA and CMS announced the RAPID coverage pathway - a new program designed to cut the historically long gap between FDA device authorization and Medicare coverage from a year or more down to as little as two months. For early-stage life science device companies, this changes the commercial math. In this episode, we break down exactly what RAPID is, who qualifies, what it mean...

Biotech in 2026 is operating inside a Triple Threat. In this episode, we break down the three forces hitting simultaneously: capital pressure that now demands commercial readiness alongside clinical proof, clinical complexity that has turned trial design into a commercial decision, and commercial infrastructure gaps that show up at the worst possible moment - right when you need them most.   If yo...